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Introduction
Infection of non-dividing cells is a hallmark of the lenti-
viruses (HIV-1, HIV-2, and the simian immunodeficiency 
viruses), setting them apart from oncoretroviruses which 
require mitosis (Lewis and Emerman, 1994). Infection of 
quiescent cells plays an important role in HIV transmis-
sion, dissemination, pathogenesis, and latency. Key to 
this process is a large nucleoprotein preintegration com-
plex (PIC) which directs the newly reverse transcribed vi-
ral cDNA through presumably intact nuclear membranes 
(reviewed in Greber and Fornerod, 2005, and Fouchier 
and Malim, 1999). The PIC remains poorly characterized 
but likely contains viral integrase, matrix, the accessory 
proteins Vpr or Vpx of HIV-1 or HIV-2/SIV, respectively, 
and viral cDNA (Bukrinsky et al., 1993, Farnet and Hasel-
tine, 1991, Karageorgos et al., 1993, and Miller et al., 1997). 
Host barrier-to-auto integration factor, histones, and the 
DNA-binding protein HMG Y(I) also assist with PIC func-
tion (Karageorgos et al., 1993, Chen and Engelman, 1998, 
Farnet and Bushman, 1997, Harris and Engelman, 2000, 
Hindmarsh et al., 1999, Li et al., 2000, and Lin and Engel-
man, 2003).
HIV-2 and other members of the lentivirus family that 
includes SIVmac and SIVsm encode a small accessory pro-
tein called Vpx. This protein is homologous to HIV-1 and 
SIV Vpr and likely arose by at least one distant gene trans-
fer event (Tristem et al., 1992, Tristem et al., 1998, and Sharp 
et al., 1996). HIV-2 also encodes a Vpr protein, however, it is 
Vpx that plays an important role in nuclear targeting simi-
lar to that of HIV-1 Vpr (Fletcher et al., 1996, Le Rouzic and 
Benichou, 2005, Pancio et al., 2000, and Popov et al., 1998a). 
Thus, the nuclear localization and cell cycle arrest functions 
of HIV-1 Vpr appear to be split in HIV-2 between Vpx and 
Vpr, respectively (Fletcher et al., 1996). Furthermore, Vpx 
is necessary for replication in macrophages (Fletcher et al., 
1996 and Pancio et al., 2000). These observations, together 
with studies linking Vpx (Hansen and Bushman, 1997) or 
Vpr to PICs, suggest an important role for Vpx in nuclear 
localization during HIV-2 infection.
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Abstract
Vpx facilitates HIV-2 nuclear localization by a poorly understood mechanism. We have compared Vpx to an NMR structure HIV-
1 Vpr in a central helical domain and probed regions of Vpx by insertional mutagenesis. A predicted loop between helices two 
and three appears to be unique, overlapping with a known novel nuclear localization signal. Overall, Vpx was found to be sur-
prisingly flexible, tolerating a series of large insertions. We found that insertion within the polyproline-containing C-terminus de-
stabilizes nuclear localization, whereas mutating a second helix in the central domain disrupts viral packaging. Other insertional 
mutants in the predicted loop and in a linker region between the central domain and the C-terminus may be useful as sites of in-
tramolecular tags as they could be packaged adequately and retained preintegration complex associated integration activity in a 
serum starvation assay. An unexpected result was found within a previously defined nuclear localization motif near aa 71. This 
mutant retained robust nuclear localization in a GFP fusion assay and was competent for preintegration complex associated nu-
clear import. In summary, we have modeled helical content in Vpx and assessed potential sites of intramolecular tags which may 
prove useful for protein–protein interactions studies.
Keywords: HIV-2, Vpx, Nuclear localization, Nuclear import
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Vpx is a virulence factor. In SIV macaque infection, Vpx 
enhances viral dissemination and pathogenesis (Igarashi et 
al., 1998 and Hirsch et al., 1998). In vitro, while dispensible 
on laboratory adapted cell lines (Hu et al., 1989, Guyader et 
al., 1989, and Marcon et al., 1991), Vpx is required for HIV-
2 and SIV replication in freshly isolated peripheral blood 
mononuclear cells (PBMCs), CD4 cells, lymphoid tissue, 
and macrophages (Park and Sodroski, 1995, Pancio et al., 
2000, Akari et al., 1992, Kawamura et al., 1994, Kappes et 
al., 1991, Yu et al., 1991, Tokunaga et al., 1997, Ueno et al., 
2003, and Rücker et al., 2004). More recently, Vpx and HIV-
1 Vpr have been implicated in up-regulation of nuclear lo-
calization in dividing lymphocytes, suggesting that even in 
a mitotic cell, the accessory proteins assist in nuclear tar-
geting (Ueno et al., 2003 and Iijima et al., 2004). Finally, Vpx 
and HIV-1 Vpr are packaged into virions via an interaction 
with the p6 domain of Gag, positioning them for partici-
pation in PIC-associated nuclear localization upon target 
cell entry (Popov et al., 1998a, Kewalramani and Emerman, 
1996, Horton et al., 1994, Wu et al., 1994, Jin et al., 2001, Pan-
cio and Ratner, 1998, Selig et al., 1999, Accola et al., 1999, 
and Mahalingam et al., 2001).
The molecular mechanism of HIV PIC nuclear trans-
port remains unclear. Although nuclear localization sig-
nals (NLS) have been described in both matrix and inte-
grase, these are neither necessary nor sufficient for nuclear 
transport (reviewed in Greber and Fornerod, 2005, Steven-
son, 1996, and Sherman and Greene, 2002). Both Vpr and 
Vpx localize to the nucleus or when overexpressed in the 
absence of Gag (Pancio et al., 2000 and Mahalingam et al., 
2001), but neither protein contains a classic NLS. Vpr binds 
to importin-α (Popov et al., 1998a) and can interact with im-
portin-β as well as dock with the nuclear pore (Popov et 
al., 1998b, Kamata et al., 2005, Gallay et al., 1997, Vodicka 
et al., 1998, and Fouchier et al., 1998). Despite these find-
ings, there is conflicting evidence implicating the impor-
tin-α/β nuclear import complex in Vpr-directed PIC trans-
port (Popov et al., 1998b and Jenkins et al., 1998). HIV PICs 
have also been observed to use importin 7 (Fassati et al., 
2003), although this pathway appears dispensible (Zielske 
and Stevenson, 2005). Furthermore, Vpr is known to in-
teract with nucleoporins (Le Rouzic et al., 2002 and Popov 
et al., 1998b). Vpr induces nuclear membrane herniations, 
which might contribute to the nuclear localization process 
(de Noronha et al., 2001). Finally, HIV-1 PICs interact with 
microtubules, which are observed to facilitate their transfer 
within 75 min after entry to the nuclear membrane region 
(McDonald et al., 2002).
Various sites in Vpr have been implicated in nuclear 
localization by mutagenesis (reviewed in Le Rouzic and 
Benichou, 2005). However, structural studies and the 
analysis of various mutants suggest that the integrity of 
a central three helix bundle is important to Vpr function 
(Morellet et al., 2003). For Vpx, deletions and mutations 
in the unique C-terminal region, which contains a stretch 
of polyproline not found in Vpr, are known to destabilize 
nuclear localization (Pancio et al., 2000 and Mahalingam 
et al., 2001). Interestingly, minimal peptide motifs near aa 
65–75 have been shown to be sufficient for nuclear local-
ization when fused to larger proteins (Mahalingam et al., 
2001, Rajendra Kumar et al., 2003, and Belshan and Ratner, 
2003). Phosphorylation of Vpx has been implicated in nu-
clear transport of SIV PICs (Rajendra Kumar et al., 2005), 
as has binding to the host cytoskeleton component actinin 
(Mueller et al., 2004).
We sought (1) to compare HIV-2 Vpx with HIV-1 Vpr in 
order to map structural domains and (2) to probe regions 
by insertional mutagenesis. One goal is to find stable inser-
tion sites that can be used as intramolecular tags. First, we 
compared a central domain against a three helix structure 
of HIV-1 Vpr. Next, we created a series of insertions in this 
region and in the C-terminus and examined Vpx packag-
ing, GFP-tagged nuclear localization, and PIC-associated 
nuclear import. Vpx was found to be surprisingly flexible, 
tolerating an array of large insertions. A predicted loop and 
a linker between the central helical region and the C-termi-
nus appear to be useful sites for engineering intramolecu-
lar tags.
Results
Predicting tertiary structure in Vpx
We sought to compare Vpx in a central region to HIV-
1 Vpr and noticed that aa 23–87 in Vpx could be simply 
threaded against a structure of HIV-1 Vpr (Morellet et al., 
2003) if five amino acids, Vpx 60–64, were taken into ac-
count as a loop (data not shown). This 5-aa sequence is pre-
dicted to be coil by various secondary structure prediction 
algorithms (Figure 1A). Low complexity regions, such as 
this, can often tolerate variability. We next aligned all of aa 
23–87 against Vpr by allowing for a 2-aa adjustment in the 
low complexity region and submitted the alignment (Fig-
ure 1B) for homology modeling by 3D Jigsaw (Bates and 
Sternberg, 1999 and Bates et al., 2001). The model (sche-
matic shown in Figure 1C) predicts a three helix bundle 
stabilized by intramolecular hydrophobic contacts and an-
chored across helices 1 and 3 by the extremely well-con-
served histidines, H39 and H82 (Figure 1D) in addition to 
L40 and V83, which are generally conserved as hydropho-
bic residues in these positions. However, K68 tends to de-
stabilize the hydrophobic core in this model. For this rea-
son, we sought gap building to better account for the low 
complexity loop using the Robetta server (Kim et al., 2004, 
Chivian et al., 2003, and Rohl et al., 2004), which uses Ro-
setta (Simons et al., 1997). The process uses energy-min-
imized constraints by simulated annealing to generate a 
comparative model and then builds gaps both by ab initio 
and homology modeling based on peptide fragments. The 
result (Figs. 1E and F) predicts similar helical content but 
shifts the loop slightly toward the C-terminus at aa 60–71 
compared to the previous models.
Recently, a leucine zipper homodimer has been demon-
strated for helix three in HIV-1 Vpr by NMR (Bourbigot et 
al., 2005). We attempted to model the corresponding region 
in Vpx (data not shown). While hydrophobic residues L72, 
I74, and V79 could be modeled, K68 tends to disrupt the di-
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mer. Furthermore, although H82 is conserved, Vpx lacks a 
tryptophan on the opposite helix three with which to make 
stacking interactions. Thus, a leucine zipper like dimer for 
Vpx helix three seems unlikely.
The predicted 60–71 loop, which contains five additional 
amino acids relative to Vpr (Figs. 1E and F), coincides pre-
cisely with a recently defined minimal nuclear localization 
motif, aa 65–72 (Rajendra Kumar et al., 2003 and Belshan 
and Ratner, 2003). This region contains 68-KYRY-71 which 
is highly conserved among Vpx sequences from a range of 
isolates (Figure 1G) but is not found in Vpr. Thus, the Vpx 
NLS appears to be both structurally and functionally dis-
tinct compared to Vpr.
The C-terminal domain can be expected to form a left-
handed type II polyproline helix, based on thermodynamic 
and structural studies of similar peptides (Rath et al., 2005 
and Sreerama and Woody, 1994). The linker region be-
tween the helical core and the polyproline tail (residues 91–
101) can be predicted as a loose coil, given the presence of 
five glycines and one proline. Overall, such an extended 
structure is ideal as a protein-binding interface, given po-
tential favorable entropic binding costs.
Figure 1. Vpx/Vpr homology region; Vpx structural predictions. (A) ROD HIV-2 Vpx secondary structure prediction by PsiPred (McGuffin et al., 
2000); aa 24–87 are shown; H represents helix, C represents random coil; the remainder of the N- and C-terminal sequences are predicted to be 
random coil. (B) Alignment of the region in Vpx (top strand) with HIV-1 Vpr (bottom strand), as predicted by Domain Fishing, with manual read-
justment of the gap region, as described in Materials and methods. Solid lines indicate identity, dark and light dashes indicate similarity. (C) Vpx 
aa 1–112 schematic. α-Helical regions predicted by 3DJigsaw, as described in Materials and methods, are indicated as H1–3. Positions H39, P41, 
and H82 are shown. (D) Remote homology sensing based on multiple Vpx and Vpr sequence alignments; positions H39 and H82 are indicated. (E) 
Vpx aa 1–112 schematic, as in panel C. α-helical regions predicted by Robetta, as described in Materials and methods, are depicted. (F) α-Helical 
region aa 23–87, as in panel E, as modeled by Robetta. The figure was rendered with DeepView (Guex and Peitsch, 1997). (G) Vpx consensus from 
multiple sequence alignments of HIV-2 and SIV Vpx.
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Insertion mutagenesis reveals differing structural requirements 
for Vpx viral particle recruitment versus nuclear localization
We hypothesized that by creating insertional muta-
tions in Vpx, we could study functional domains and at the 
same time find favorable sites for intramolecular tagging. 
A series of 19-aa insertions were generated by transposon-
based mutagenesis, and a panel was chosen: Insertion (Ins) 
52, at the predicted second helix; Ins 71, within the NLS; 
Ins 91, at the linker between helix three and the polyproline 
tail; and Ins 106, within the polyproline motif (Figure 2A). 
It should be noted that the transposition mechanism leaves 
small duplications. For example, Ins 52 caused duplication 
of 51-SW-52, whereas Ins 71 resulted in duplication of 69-
YRY-71 (Figure 2A). Ins 106 recreated proline 107, because 
of the wobble base at codon 106, and had the net effect of 
duplicating 105-PP-106 (Figure 2A). Next, a His5 insertion 
adjacent to H57 was created by site-specific mutagenesis. 
This site was chosen because early simple threading mod-
els predicted flexibility at the end of helix 2.
Figure 2. Insertion mutations. (A) Positions and sequence of transposition-mediated 19-aa insertions and polyhistidine insertion in the Vpx se-
quence. H1–3 correspond to helices as in Figs. 1F. (B) Western blots of purified viral particles probed for Vpx (upper) or viral capsid (CA) (lower). 
(C) Cellular lysates used to produce virus as in panel B. Note that a lower resolving SDS-PAGE gel was used, and thus, the migration patterns ap-
pear similar for the various mutants; Western blots probed for Vpx or CA. (D) Plot of normalized ratio of Vpx or Vpx mutants:CA localized to vi-
ral particles.
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The insertion mutants were analyzed for viral parti-
cle incorporation by constructing mutant HIV-2 molecu-
lar clones and transfecting them into 293T cells. Viral parti-
cles were isolated. As shown in Figure 2B, all of the mutant 
proteins were packaged. After normalizing for total Vpx to 
HIV-2 capsid (CA) ratios expressed in the cellular lysates 
(Figure 2C), the efficiency of Vpx recruitment was assessed 
by taking the ratio of Vpx/CA in the viral particles (Fig-
ure 2D). Ins 52 was the most severely compromised, pack-
aged at 6% compared to wild type, whereas Ins 57, 71, 91, 
and 106 were moderately decreased; 55, 20, 30, and 31%, 
respectively.
Next, we studied nuclear localization by overexpressing 
the insertion mutants as GFP fusions. As shown in Figure 
3, wild-type Vpx accumulated in the nucleus, as expected. 
Tiny cytoplasmic inclusion bodies were observed (Figure 
3, arrows). Ins 52 localized to the nucleus, also with scat-
tered punctuate cytoplasmic inclusions (Figure 3, arrows). 
Ins 57 and 106 showed relatively poor nuclear localization, 
with more diffuse cytoplasmic distribution (Figure 3). Ins 
91 consistently localized to the nucleus but caused a toxic 
appearance to cells (Figure 3). The most striking result was 
Ins 71, which localized uniformly to the nucleus and did 
not form inclusion bodies (Figure 3).
Integration activity of the insertion mutants
Next, the insertion mutants were studied in an infection 
assay in serum-starved cells to test for active nuclear local-
ization in the context of the HIV-2 PIC. In this assay, am-
photropic MLV-pseudotyped HIV-2 viruses are used to 
infect arrested monocytic U937 cells during a short incuba-
tion. A nested PCR technique similar to that described by 
Brussel et al. (2005) counts integration events in the chro-
mosomal DNA, presumably reflecting successful negotia-
tion of the nuclear envelope. The first round of PCR is a lin-
ear round using primers against the repetitive and widely 
distributed Alu chromosomal sequences together with a 
tagged HIV-2 LTR primer. The second round is a quanti-
tative, real-time, round using primers complementary to 
the tag and the LTR together with an internal fluorescent 
probe. As shown in Figure 4, wild-type Vpx virus is much 
more efficient than ΔVpx for nuclear localization in this as-
say (lanes 1 and 2), as expected. Ins 106 showed severely 
compromised function, similar to ΔVpx (Figure 4, lane 7). 
Ins 52 was strongly reduced (Figure 4, lane 3), whereas Ins 
57, 71, and 91 were moderately decreased relative to wild-
type virus nuclear localization (Figure 4, lanes 4–6).
Figure 3. Localization of Vpx mutants by GFP fusion. HeLa cell transfections visualized by fluorescent microscopy. Arrows point to cytoplasmic 
inclusion bodies.
Figure 4. PIC-mediated viral nuclear localization in non-dividing cells. 
Plots of total chromosomal integrations, as measured by an Alu-based 
method, for wild-type or mutant Vpx viruses.
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Discussion
Structural predictions in Vpx
Because the modeled helical region (Figure 1F) coin-
cides precisely with the most highly conserved sequences 
between Vpx and Vpr, a three helix bundle structure seems 
likely. Furthermore, the fact that H39 and H82 are ex-
tremely well conserved across all Vpx and Vpr sequences 
(Figure 1D) points to a structural role for such a configu-
ration. In fact, a recent study showed SIV Vpx H82A to be 
compromised for nuclear localization and mutant virus 
that was deficient for replication in macrophages (Mahal-
ingam et al., 2001). Considering diverse Vpx sequences, as 
shown in Figure 1G, it is apparent that hydrophobic res-
idues predicted to stabilize the central core are well con-
served, including residues 25I, 29V, 32I, 37V, 40L, 44L, 45I, 
48V, 72L, 74I, and 75M.
Proline at position 41 is predicted to adopt a trans-con-
figuration stabilizing the first turn in the helical bundle, 
analogous to Vpr P35 (Bruns et al., 2003 and Morellet et al., 
2003) (Figure 1F). Proline in this region is highly conserved 
among Vpx and Vpr sequences, at various positions within 
the turn. Interestingly, host cyclophilin, a prolyl isomerase, 
binds to Vpr at proline in the first turn and is important 
for stable Vpr expression (Zander et al., 2003). Preliminary 
evidence demonstrates an analogous dependence of HIV-2 
Vpx on cyclophilin, substantiating the idea that the confor-
mation of Vpx may be similar to Vpr (data not shown).
At this time, the function of a leucine zipper for Vpr re-
mains unclear. In any event, based on the modeling dis-
cussed here, it seems unlikely that Vpx would be able to 
adopt an analogous dimer involving helix three. This po-
tential structural difference might reflect differing func-
tions. For example, Vpr has been implicated in a wide ar-
ray of activities not known for Vpx including transcription 
activation, regulation of apoptosis, and the well-charac-
terized G2 arrest (reviewed in Le Rouzic and Benichou, 
2005).
Viral packaging
Surprisingly, the insertion mutations were broadly tol-
erated for viral packaging in that mutating the helical do-
main or C-terminus did not completely abrogate this func-
tion. However, Vpx Ins 52 was severely compromised, 
suggesting that either an intact helix two or exposed face 
of helix two is important for the interaction with Gag. On 
the other hand, Ins 106 retained viral packaging, suggest-
ing that the polyproline tail is not critical for Gag binding. 
The helical model (Figs. 1E and F) predicts a loop adjacent 
to Ins 57 and 71 and a linker region at the site of Ins 91, be-
tween the helical domain and the C-terminus. The mutants 
Ins 57, 71, and 91 retained adequate viral packaging, sug-
gesting that the loop and linker are flexible enough to toler-
ate variation.
Previous studies have shown that Vpx or Vpr can toler-
ate a wide range of mutations and still be packaged into vi-
rions. For Vpx, the Gag interaction domain would appear 
to be located between aa 64 and 89, since deletion N- or C-
terminal to these positions, respectively, does not abrogate 
recruitment into particles (Pancio et al., 2000 and Mahalin-
gam et al., 2001). Furthermore, internal deletion of aa 73–89 
did not disrupt viral particle incorporation (Jin et al., 2001). 
This would leave aa 64–73 as a possible minimal Gag in-
teraction domain, which coincides with the loop and the 
NLS in the model of the protein described here. However, 
in a previous study, SIV Vpx aa 60–85 fused to GFP was 
found to be insufficient for viral particle localization (Ma-
halingam et al., 2001). Ins 71 supports this observation, in 
that the mutant protein could still be packaged. In terms 
of the overall three helix bundle, a previous study showed 
that mutating the extremely conserved histidine at position 
82 did not affect viral packaging (Mahalingam et al., 2001), 
a mutation which is predicted to disrupt the helical bundle 
structure. Thus, it appears that neither an intact three helix 
bundle, as modeled here, nor the NLS-loop region is criti-
cal for viral packaging. The precise residues involved in vi-
ral packaging remain to be determined.
Nuclear localization by GFP fusion assay
The phenotype of Vpx Ins 106 (Figure 3) confirms a pre-
vious result in which Vpx was truncated C-terminal to aa 
110, resulting in destabilization of nuclear localization 
(Pancio et al., 2000). Thus, the highly conserved polyproline 
motif contributes to efficient nuclear localization.
A surprising result was found with Ins 71. This muta-
tion disrupts the NLS motif, 65-SYTKYRYLCIM-75, as de-
fined by Belshan and Ratner (2003). Yet, the mutant local-
ized uniformly to the nucleus in the GFP assay (Figure 3). 
In the study of Belshan and Ratner, 3 aa at the C-termi-
nal end of the peptide did not seem necessary for the NLS 
function, given the fact that an 11-aa sequence, aa 61–72, 
could also mediate nuclear localization. Because the net ef-
fect of Ins 71 is to disrupt the motif after position 71, the 
observations suggest that L72 is not critical for the NLS 
signal. There may be various reasons contributing to the 
good performance of Ins 71 in this assay including in-
creased solubility or an extended structure exposing the 
NLS. In fact, Ins 71 did not form inclusion bodies in the 
GFP assay (Figure 3). In terms of sequence, the random 19-
aa insertion caused duplication of K/R-Y-R-Y (Figure 2A), 
a motif that is very well conserved among HIV-1/SIV iso-
lates (Figure 1G). Because a recent study of SIV Vpx con-
firmed aa 61–80 to be sufficient for nuclear entry and that 
mutation of K68A did not disrupt nuclear localization (Ra-
jendra Kumar et al., 2003), 69-YRY-71 may be the most crit-
ical residues. For HIV-2 ROD Vpx, we have recently dem-
onstrated the importance of R70, when mutated together 
with K68, and Y69 for the nuclear localization signal 
(Belshan et al., in press).
PIC-associated nuclear localization by Alu integration
In this sensitive, non-dividing cell assay induced by se-
rum starvation, Vpx was observed to enhance PIC nuclear 
localization (Figure 4, lanes 1 and 2). The relative activities 
of Ins 52, 57, 71, and 91 in this assay are similar to the rel-
ative packaging efficiencies of these mutants as compared 
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to wild type (compare Figure 4, lanes 3–5 with Figure 2D). 
Thus, the overall effect of the mutations on PIC activity ap-
pears to be minimal. The results confirm those of the GFP 
nuclear localization assay in the case of Ins 52 and 71. Why 
Ins 57 behaves poorly in the GFP assay is unclear but might 
be explained by toxic or artifactual effects of overexpress-
ing the mutant protein. Clearly, overexpression of Ins 91 
caused toxicity to the cells in the GFP assay.
Ins 106 appeared to be severely compromised for PIC 
function in the non-dividing cell assay, suggesting an im-
portant role of the polyproline motif in PIC-associated nu-
clear localization. This result is in agreement with the de-
stabilization of nuclear localization observed in the GFP 
assay and confirms previous observations mutating this C-
terminal region (Pancio et al., 2000).
An alternate test of PIC nuclear localization would be to 
test the Vpx mutant viruses for infection of macrophages. 
However, the ROD HIV-2 isolate is defective for efficient 
macrophage infection for reasons that are unclear at this 
time.
Summary
One goal of these experiments is to identify regions in 
Vpx that are suitable for intramolecular tagging. Insertion 
site 106 appears to be a poor candidate, given the disrup-
tion of both PIC associated and GFP fusion nuclear localiza-
tion. Ins 57 appears to retain PIC activity and incorporates 
relatively well into viral particles but performed poorly in 
the GFP assay, which may be subject to artifact given the 
high levels of overexpressed protein. Indeed, Ins 91 caused 
toxicity to cells in the GFP assay but appeared to retain PIC 
integration activity as well as adequate viral packaging. Fi-
nally, the phenotype of Ins 71 is unexpected. The mutant 
sequence suggests that leucine at position 72 is not impor-
tant to the NLS. The mutant protein showed strong nuclear 
localization as a free GFP fusion, was non-toxic, did not 
form inclusion bodies, retained adequate viral packaging, 
and appeared to be stable for PIC function. In summary, 
the best candidates for stable insertion sites are clustered 
around the NLS-loop region, near aa 57–71, or within the 
helical domain/C-terminus linker, near aa 91.
Viruses have evolved a variety of strategies for har-
nessing the nuclear pore. For HIV-2, the mechanism of nu-
clear localization appears unique but remains poorly un-
derstood. Characterizing the molecular details of retroviral 
preintegration complexes and associated host interactions 
should highlight novel therapeutic targets as well as basic 
mechanisms of nuclear entry.
Materials and methods
Homology modeling
Amino acids 23–87 in the HIV-2 ROD Vpx primary se-
quence were aligned with residues 17–76 of HIV-1 Vpr 
by Domain Fishing (Bates et al., 2001). The alignment re-
sulted in 5 extra aa in Vpx, aa 62–66, coinciding with coil 
predicted by PsiPred (McGuffin et al., 2000) in the region 
aa 56–66. Because the region is low complexity, we man-
ually adjusted the alignment by moving the gap to Vpx aa 
60–64 and submitted to 3D Jigsaw against PDB 187L (Mo-
rellet et al., 2003, Bates and Sternberg, 1999, Bates et al., 
2001 and Contreras-Moreira and Bates, 2002). To build 
the gap, a full-length alignment was submitted to the Ro-
betta/Rosetta modeling server against Vpr PDB 187L (Kim 
et al., 2004, Chivian et al., 2003 and Rohl et al., 2004). For 
the third helix dimerization domain, Vpr coordinates were 
kindly supplied by Bourbigot et al. (2005). The correspond-
ing region of Vpx was fit manually using Swiss-PdbViewer 
(Schwede et al., 2003), and the dimer was modeled by 
Swiss-Model. For Vpx consensus building, the Vpx HIV-
2/SIV alignment from the Los Alamos HIV sequence da-
tabase, http://www.hiv.lanl.gov/content/hiv-db/main-
page.html, was converted into a sequence logo (Crooks et 
al., 2004). The height of the letters represents the relative 
frequency of that residue at the given position (Schneider 
and Stephens, 1990). For Vpx/Vpr remote homology sens-
ing by hidden Markov models, the SAM-99 server, http://
www.cse.ucsc.edu/research/compbio/sam.html, was 
used (Karplus et al., 1998, Krogh et al., 1994 and Hughey 
and Krogh, 1996).
Proviral constructs
A subcloning cassette containing a 587 bp fragment of 
the ROD10 (Bour et al., 1996) proviral clone was used such 
that a SacI site at bp 5704 has been mutated but does not al-
ter the vpr open reading frame (Pancio et al., 2000). A series 
of random insertion mutations were made by the method of 
EZ:Tn (Epicentre, Madison, WI) (Goryshin and Reznikoff, 
1998). After sequencing, candidate insertions were chosen, 
and the bulk of the transposon was removed by restriction 
digestion with NotI followed by religation. This procedure 
leaves random 19-aa insertions in every reading frame, 
with 9 bp of the original DNA sequence duplicated at ei-
ther end. The modified regions were then digested with 
SacI and cloned into the ROD10 vector. The polyhistidine 
mutant was constructed using mutagenic primers coding 
for five histidines adjacent to the natural histidine at posi-
tion 57 using the QuikChange method (Stratagene, La Jolla, 
CA). The ΔVpx construct contains mutations at the initi-
ating and first internal methionines of Vpx such that the 
reading frame of vpr is intact (Hu et al., 1989).
Transfections, viral particle isolation, and Western blotting
293T cells were transfected with proviral DNA in Dul-
becco’s modified Eagle’s Medium (DMEM) supplemented 
with 10% fetal calf serum and antibiotics, using Transit-
LTI (Mirus Bio, Madison, WI) according to the manufac-
turer’s directions. AT 72 h, the supernatant was cleared 
by low speed centrifugation, layered on 20% sucrose, and 
subjected to ultracentrifugation at 26,000×g for 90 min. The 
pellet was resuspended in SDS-PAGE sample buffer, boiled 
for 10 min in the presence of DTT, and loaded on Tris–tri-
cine SDS-PAGE. After blotting onto PVDF membranes, the 
blots were probed with a monoclonal anti-Vpx antibody 
(NIH AIDS Research and Reference Reagent Program, 
6D2.6) or an anti-p24 capsid monoclonal antibody that 
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cross reacts with HIV-2 p27, both of which had been pre-
viously purified on protein A sepharose beads (Sigma, St. 
Louis, MO) from hybridoma culture. The blots were devel-
oped with anti-mouse horseradish peroxidase antibody fol-
lowed by SuperSignal West Femto substrate (Pierce, Rock-
ford, IL) and imaged and quantitated on chemiluminescent 
Alpha Imager (Alpha Innotech, San Leandro, CA). For the 
cellular lysates, the 293T cells were lysed in SDS sample 
buffer and loaded onto 12% Tris SDS-PAGE, followed by 
Western blotting.
GFP fusion nuclear localization
Insertion mutations were cloned into pEGFPC1 (Clon-
tech) using BamHI and EcoRI sites, resulting in fusion to 
the GFP open reading frame at the Vpx N-terminus driven 
by a constitutive CMV-based promoter. 105 HeLa cells 
grown on coverslips were transfected with 2 μg of DNA in 
duplicate in 6-well tissue culture plates, DMEM medium 
supplemented with 10% fetal calf serum and antibiotics, 
and Transit-LTI (Mirus Bio, Madison, WI), according to 
the manufacturer’s instructions. After 16 h, the cells were 
fixed with 2% paraformaldehyde, treated with 0.1% Triton 
X-100 for 5 min, then stained with Hoechst 33258 (Molecu-
lar Probes, Eugene, OR). The coverslips were mounted, and 
the cells were visualized using a fluorescence microscope 
equipped with an Optronics Magnafire imaging system 
(Optronics, Goleta, CA). Multiple images were obtained 
and compared from three independent transfections.
Alu integration assay
Amphotropic MLV pseudotyped HIV-2 ROD viruses 
were prepared by transfection of 293T cells in the presence 
of 1:5 μg ratio of a CMV driven amphotropic MLV env 
plasmid DNA to molecular clone ROD DNA using Transit-
LTI in DMEM medium supplemented with 10% fetal calf 
serum and antibiotics, according to the manufacturer’s di-
rections. After 72 h, the supernatants were cleared by low-
speed centrifugation, and viral particles were quantitated 
by simian immunodeficiency virus ELISA (Coulter, Miami, 
FL). U937 monocyte cells (ATCC CRL-1593.2) were plated 
at 106 cells per well in 12-well tissue culture dishes after 
washing and diluting in 0% fetal calf serum RPMI-1640 
media (Gibco, Grand Island, NY) supplemented with an-
tibiotics. After 48 h, 100 ng virus was added, and the reac-
tions were incubated for 4 h at 37 °C in a humidified, CO2 
supplemented incubator. The cells were washed in phos-
phate-buffered saline and genomic DNA was prepared us-
ing the Qiagen (Valencia, CA) Mini Blood DNA kit. A lin-
ear round of PCR was performed for 12 cycles, with 3-min 
extension, 60 °C annealing temperature and the following 
primers: ATGCCACGTAAGCGAAACTGC GAGGCTG-
GCAGATTGAGCCCTG, which contains a 5′ tag sequence 
(underlined) and is complementary at the 3′ end to the HIV-
2 ROD LTR; TCCCAGCTACTGGGGAGGCTGAGG, an 
Alu complementary primer; and GCCTCCCAAAGTGCT-
GGGATTACAG, an Alu complementary primer. A quanti-
tative real-time round was then performed using iQ Super-
mix (Biorad, Hercules, CA), 60 °C annealing temperature, 
30-s extension, and the following primers: ATGCCACGTA-
AGCGAAACTGC, containing the tag sequence; TTACT-
CAGGTGAACACCGAATGACCAGGC, complementary 
to the HIV-2 LTR; and 5′-FAM-TCCCATCTCTCCTAGTC-
GCCGCCT-3′-Iowa Black, as a probe. The standards were 
dilutions of genomic DNA prepared in the same way from 
U937 cells chronically infected with ROD HIV-2.
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